hotspot -WSS

hotspot

author：explore 2025-09-02 08:23:15 - browse：1

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Wikipedia

explore

WSS

Diagnostic tests are hitting their mathematical limits

What we know about the American soldier detained in North Korea

UK homeowners get some respite as inflation falls by more than anticipated to a 15

House passes resolution saying Israel isn't a 'racist or apartheid state'

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

What to do when lifesaving products contribute to climate change

explore

hotspot

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Will the market for weight loss drugs really reach $100 billion?

The high cost of giving birth even with insurance

FDA seeking to stop procedures at two unregulated stem cell clinics

Drug repurposing or repositioning? The language matters

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Moonlake's readout produced a cash windfall. Risks remain

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Anesthesiologist group: stop taking Ozempic before surgery

Study: Hearing aids may slow cognitive decline in those at risk

focus

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Pediatric cancer treatments threatened by a new FDA policy

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

30 years of 'Listening to Prozac'

Manchin plays down potential 3rd

knowledge

Wikipedia

explore

focus